| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-05 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-05 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-05 |